View:
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
May 15, 2007
-------------------
(Date of earliest event reported)
LABORATORY CORPORATION OF AMERICA HOLDINGS
------------------------------------------
(Exact name of registrant as specified in its charter)
DELAWARE 1-11353 13-3757370
-------------- ----------- --------------
(State or Other (Commission (IRS Employer
Jurisdiction of File Number) Identification
Incorporation) Number)
358 SOUTH MAIN STREET
BURLINGTON, NORTH CAROLINA 27215
--------------------------------------- -------
(Address of principal executive offices) (Zip Code)
336-229-1127
------------
(Registrant's telephone number, including area code)
N/A
---------------------------------------
(Former name or former address, if changed since last report.)
Check the appropriate box below if the Form 8-K filing is intended to
simultaneously satisfy the filing obligation of the registrant under any of
the following provisions:
[ ] Written communications pursuant to Rule 425 under the Securities Act
(17 CFR 230.425)
[ ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act
(17 CFR 240.14a-12)
[ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the
Exchange Act (17 CFR 240.14d-2(b))
[ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the
Exchange Act (17 CFR 240.13e-4(c))
ITEM 7.01. Regulation FD Disclosure
On May 15, 2007 - Laboratory Corporation of America(R) Holdings (LabCorp(R))
today announced that its Annual Meeting of Shareholders will be webcast live
beginning May 16, 2007 at 9:00 a.m. Eastern Time via the Company Web site at
www.labcorp.com. An archived replay of the audio webcast will be available
through June 16, 2007.
The press release dated May 15, 2007 is attached herewith as Exhibit 99.1.
Exhibits
99.1 Press Release dated May 15, 2007
SIGNATURES
Pursuant to the requirements of the Securities and Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
LABORATORY CORPORATION OF AMERICA HOLDINGS
------------------------------------------
(Registrant)
By:/s/ BRADFORD T. SMITH
--------------------------------------
Bradford T. Smith
Executive Vice President and Secretary
Date: May 15, 2007
Laboratory Corporation of America(R) Holdings
358 South Main Street
Burlington, NC 27215
Telephone: (336) 584-5171
FOR IMMEDIATE RELEASE
Investor Contact: Scott Fleming - 336-436-4879
Media Contact: Pam Sherry - 336-436-4855
Shareholder Direct: 800-LAB-0401
Company Information: www.labcorp.com
LABCORP(R) SCHEDULED TO WEBCAST ITS ANNUAL
MEETING OF STOCKHOLDERS
Burlington, NC, May 15, 2007 - Laboratory Corporation of America(R)
Holdings (LabCorp(R)) (NYSE: LH) today announced that its Annual Meeting
of Shareholders will be webcast live beginning May 16, 2007 at 9:00 a.m.
Eastern Time via the Company Web site at www.labcorp.com. An archived
replay of the audio webcast will be available through June 16, 2007.
About LabCorp(R)
- ----------------
Laboratory Corporation of America(R) Holdings, a S&P 500 company, is a
pioneer in commercializing new diagnostic technologies and the first in
its industry to embrace genomic testing. With annual revenues of $3.6
billion in 2006, over 25,000 employees nationwide, and more than 220,000
clients, LabCorp offers clinical assays ranging from routine blood
analyses to HIV and genomic testing. LabCorp combines its expertise in
innovative clinical testing technology with its Centers of Excellence:
The Center for Molecular Biology and Pathology, National Genetics
Institute, Inc., ViroMed Laboratories, Inc., The Center for Esoteric
Testing, DIANON Systems, Inc., US LABS, and Esoterix and its Colorado
Coagulation, Endocrine Sciences, and Cytometry Associates laboratories.
LabCorp clients include physicians, government agencies, managed care
organizations, hospitals, clinical labs, and pharmaceutical companies. To
learn more about our growing organization, visit our Web site at:
www.labcorp.com.
Each of the above forward-looking statements is subject to change based
on various important factors, including without limitation, competitive
actions in the marketplace and adverse actions of governmental and other
third-party payors. Actual results could differ materially from those
suggested by these forward-looking statements. Further information on
potential factors that could affect LabCorp's financial results is
included in the Company's Form 10-K for the year ended December 31, 2006,
and subsequent SEC filings.